Biomaterial choice is an essential step during the development tissue engineering and
regenerative medicine (TERM) applications. The selected biomaterial must present …

Tissue engineering (TE) offers a potential solution for the shortage of transplantable organs
and the need for novel methods of tissue repair. Methods of TE have advanced significantly …

Despite the enthusiasm for bioengineering of functional renal tissues for transplantation,
many obstacles remain before the potential of this technology can be realized in a clinical …

Allogeneic liver transplantation is still deemed the gold standard solution for end-stage
organ failure; however, donor organ shortages have led to extended waiting lists for organ …

The rising number of patients needing renal replacement therapy, alongside the significant
clinical and economic limitations of current therapies, creates an imperative need for new …

End-stage renal disease (ESRD) is characterized by the progressive deterioration of renal
function that may compromise different tissues and organs. The major treatment indicated for …

The outcome of tissue engineered organ transplants depends on the capacity of the
biomaterial to promote a pro-healing response once implanted in vivo. Multiple studies …

Renal transplantation is currently the most effective treatment for end-stage renal disease,
which represents one of the major current public health problems. However, the number of …

Interactions between the pancreatic extracellular matrix (ECM) and islet cells are known to
regulate multiple aspects of islet physiology, including survival, proliferation, and glucose …

Chronic kidney disease is a major global health problem affecting millions of people; kidney
tissue engineering provides an opportunity to better understand this disease, and has the …